Digital Strategies to Advance Help-Seeking Aim 1 and 2

Recruiting Observational Study
Clinical High Risk Early Psychosis First Episode Psychosis
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 29
Sex
Any
Study type
Observational
Participants needed
25,000 (estimated)
Sponsor
Columbia University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This proposal aims to establish a Digital Laboratory focused on advancing help-seeking and expediting treatment initiation in youth ages 12-29 who are at Clinical High-Risk (CHR) for developing psychosis. Leveraging the Health Action Process Approach (HAPA) model, this study will identify help-seeking subtypes in 25,000 youth who screen positive for psychosis-risk on Mental Health America's nation…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Ages 12-29 years * Living within a 50-mile radius of a US based AMP-SCZ site * Able to complete the English language PQ-B on MHA's screening platform
Contacts

Michael Birnbaum, MD

212-523-2154

mlb2216@cumc.columbia.edu

CONTACT